Medicinal chemistry and pharmacology of gold compounds

Transition Metal Chemistry

Volumn 21, Issue 4, 1996, Pages 377-383

  Fricker, Simon P ^a  

^a JOHNSON MATTHEY TECHNOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000664351     PISSN: 03404285     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00139037     Document Type: Article

References (54)

1. J. J. R. Frausto da Silva and R. J. P. Williams, The Biological Chemistry of the Elements, 1st Edit., Clarendon Press, Oxford, 1991.
2. P. J. Sadler, Adv. Inorg. Chem., 36, 1 (1991).
3. C. F. J. Barnard, S. P. Fricker and O. J. Vaughan, in D. Thompson (Ed.), Insights into Speciality Inorganic Chemicals, 1st Edit., Royal Society of Chemistry, Cambridge, 1995, p. 35.
4. G. J. Higby, Gold Bull, 15, 130 (1982).
5. R. V. Parish, Interdisc. Sci. Rev., 17, 221 (1992).
6. R. Koch, Dtsch. Med. Wochenschr., 16, 756 (1890).
7. K. Landé, Münch. Med. Wochenschr., 74, 1132 (1927).
8. J. Forestier, J. Lab Clin. Med., 20, 827 (1935).
9. T. G. Davis (Ed.), Scand. J. Rheumatol. Suppl., 63, (1986).
10. P. J. Sadler, Struct. Bonding, 29, 171 (1976).
11. C. F. Shaw III, Inorg. Persp. Biol. Med., 2, 278 (1979).
12. D. H. Brown and W. E. Smith, Chem. Soc. Rev., 9, 217 (1980).
13. C. F. Shaw III, Comments Inorg. Chem., 8, 233 (1989).
14. C. F. Shaw III and M. M. Savas in M. J. Stillman, C. F. Shaw III and K. T. Suzuki (Eds), Metallothioneins: Synthesis, Structure, and Properties of Metallothioneins, Phytochelatins and Metal-Thiolate Complexes, VCH, New York, 1992, p. 144.
15. C. Moncur and H. J. Williams, Phys. Ther., 75, 511 (1995).
16. R. V. Parish and S. M. Cottrill, Gold Bull., 20, 3 (1987).
17. R. C. Elder and M. K. Eidness, Chem. Rev., 87, 1027 (1987).
18. N. L. Gottlieb, J. Rheumatol., 9 (Suppl. 8), 99 (1982).
19. R. M. Snyder, C. K. Mirabelli and S. T. Crooke, Semin. Arthritis Rheum., 17, 71 (1987).
20. M. Grootveld, D. R. Blake, T. Sahinoglu, A. W. D. Claxson, P. Mapp, C. Stevens, R. E. Allen and A. Furst, Free Rad. Res. Comms., 10, 199 (1990).
21. G. D. Champion, G. G. Graham and J. B. Ziegler, Balliéré's Clin. Rheumatol., 4, 491 (1990).
22. J. H. Liebarth and R. H. Persellin, Agents and Actions, 11, 458 (1981).
23. E. Choy and G. Kingsley, Br. Med. Bull., 51, 472 (1995).
24. M. L. Handel, C. K. W. Watts, A. deFazio, R. O. Day and R. L. Sutherland, Proc. Natl. Acad. Sci. USA, 92, 4497 (1995).
25. D. T. Walz, M. J. Dimartino and D. E. Griswold, J. Rheumatol., 9 (Suppl. 8), 54 (1982).
26. D. T. Felson, J. J. Anderson and R. F. Meenan, Arthritis Rheum., 33, 1449 (1990).
27. M. Harth, J. Rheumatol., 20, 771 (1993).
28. M. H. Pioro and J. M. Cash, Rheum. Dis. Clin. North Am., 21, 129 (1995).
29. R. E. Thomas and R. A. Papandrea, Med. J. Aust., 158, 720 (1993).
30. B. A. Becker and A. A. Gaspari, Dermatol. Clin., 11, 429 (1991).
31. A. D. Ormerod, Drugs, 48, 717 (1994).
32. O. M. Ni Dhubhghaill and P. J. Sadler in B. K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, 1993, p. 221.
33. C. F. Shaw III in S. P. Fricker (Ed.), Metal Compounds in Cancer Therapy, Chapman & Hall, London, 1994, p. 46.
34. S. J. Berners-Price, C. K. Mirabelli, R. K. Johnson, M. R. Mattern, F. L. McCabe, E. F. Faucette, C. M. Sung, S. M. Mong, P. J. Sadler and S. T. Crooke, Cancer Res., 46, 5486 (1986).
35. C. K. Mirabelli, R. K. Johnson, S. T. Crooke, M. R. Mattern, S. M. Mong, C. M. Sung, G. Rush, S. J. Berners-Price, P. S. Jarrett and P. J. Sadler in M. Nicolini and G. Bandoli (Eds), 5th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, 1987, p. 319.
36. S. J. Berners-Price, P. S. Jarrett and P. J. Sadler, Inorg. Chem., 26, 3074 (1987).
37. G. D. Hoke, R. A. Macia, P. C. Meunier, P. J. Bugelski, C. K. Mirabelli, G. F. Rush and W. D. Matthews, Toxicol. Appl. Pharmacol., 100, 293 (1989).
38. R. V. Parish, B. P. Howe, J. P. Wright, J. Mack, R. G. Pritchard, R. G. Buckley, A. M. Elsome and S. P. Fricker, Inorg. Chem., 35, 1659 (1996).
39. T. H. Corbett, F. A. Valeriote and L. H. Baker, Invest. New Drugs, 5, 205 (1987).
40. S. P. Fricker in S. P. Fricker (Ed.), Metal Compounds in Cancer Therapy, Chapman & Hall, London, 1994, p. 1.
41. S. P. Fricker in Ph. Collery, L. A. Poirier, M. Manfait and J.-C. Etienne (Eds), Metal Ions in Biology and Medicine, John Libby Eurotext, Paris, 1990, p. 452.
42. L. Girgis, P. G. Conaghan and P. Brooks, Curr. Opin. Rheumatol., 6, 252 (1994).
43. M. D. Rhodes, P. J. Sadler, M. D. Scawen and S. Silver, J. Inorg. Biochem., 46, 129 (1992).
44. W. Brumfitt and J. M. T. Hamilton-Miller, Drugs Exptl. Clin. Res., 16, 205 (1990).
45. A. P. Johnson, A. H. C. Uttley, N. Woodford and R. C. George, Clin. Microbiol. Rev., 3, 280 (1990).
46. A. M. Elsome, W. Brumfitt, J. M. T. Hamilton-Miller, P. D. Savage, R. O. King and S. P. Fricker, in Program and Abstracts of the 31st Interscience Conference on Anti-Microbial Agents and Chemotherapy, Chicago, American Society for Microbiology, Washington, DC, 1991, Abstract 387, p. 163.
47. A. M. Elsome, J. M. T. Hamilton-Miller, W. Brumfitt and W. C. Noble, J. Antimicrob. Chemother., 37, 911 (1996).
48. S. P. Fricker, Toxic. in Vitro, 8, 879 (1994).
49. R. V. Parish, J. Mack, L. Hargreaves, J. P. Wright, R. G. Buckley, A. M. Elsome, S. P. Fricker and B. R. C. Theobald, J. Chem. Soc., Dalton Trans., 69 (1996).
50. M. G. Peterson and V. R. Baichwal, TIBTECH, 11, (1993).
51. A. Travers, DNA-Protein Interactions, 1st Edit., Chapman & Hall, London, 1993, p. 52.
52. D. P. Hollywood and H. C. Hurst, Br. J. Cancer, 71, 753 (1995).
53. M. L. Handel, A. deFazio, C. K. W. Watts, R. O. Day and R. L. Sutherland, Molec. Pharmacol., 40, 613 (1991).
54. M. L. Handel, C. K. W. Watts, A. deFazio, R. O. Day and R. L. Sutherland, Proc. Natl. Acad. Sci. USA, 92, 4497 (1995).